from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2400c/subI

LFCtreatmentdescriptionclass of inhibitor

0.362

Amikacinug/mL Amikacintranslation

1.251

Cap5-10ug/mL Capreomycintranslation

0.995

Rox10-50 ug/mL Roxithromycintranslation

0.507

SM2-5 ug/mL Streptomycintranslation

-1.014

Tet5-10 ug/mL Tetracyclinetranslation

0.366

Rif0.2-5ug/mL Rifampicintranscription

0.745

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.763

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.820

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.363

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.852

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.166

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.311

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.124

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.095

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.177

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.385

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.265

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.072

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.400

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.107

KCN5-20 ug/mL Potassium cyaniderespiration

0.282

NaN30.2-2 mM Sodium aziderespiration

0.602

Nigericin50 uM Nigericinrespiration

-0.182

TRC10-150 ug/mL Triclosanrespiration

0.322

TRZ10-25 ug/mL Thioridazinerespiration

0.860

Valinomycin0.5-10 uM Valinomycinrespiration

1.383

ZnSO42 mM ZnSO4respiration

1.808

menadione6-10 ug/mL Menadionerespiration

0.133

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.063

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.006

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.041

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.547

NRP_1Non-replicating persistence stage 1dosRassociated

-0.142

Amp0.2mg/mL AmpicillincellWall

0.082

Cephalexin20-100 ug/mL CephalexincellWall

0.141

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.404

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.620

EMB10-20 ug/mL EthambutolcellWall

-0.669

Eta12-40 ug/mL EthionamidecellWall

-0.994

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.502

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.822

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.333

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.443

BZA0.12 mg/mL BenzamidearomaticAmides

-0.924

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.042

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.288

H2O24 mM hydrogen peroxideDNAdamaging

-0.225

Levo10 ug/mL LevofloxacinDNAdamaging

0.099

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.958

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.386

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.304

UVUV-irradiationDNAdamaging

4.048

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.060

Antimycin12.5-50 ug/mL Antimycin A?

0.752

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.575

PA_110-50 ug/mL Antitubercular compound PA-1?

0.104

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.082

PA8240.2-2 ug/mL PA-824?

1.336

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.119

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.437

Verapamil50 uM Verapamil?

0.207

mercaptoethanol2 mM 2-Mercaptoethanol?

0.732

methoxatin10-20 ug/mL Methoxatin?